2011 report on adverse events following immunisation in Australia
Jan 2013 - News
Published in the December 2012 issue of Communicable Diseases Intelligence this report summarises Australian surveillance data for adverse events following immunisation (AEFI) reported to the Therapeutic Goods Administration (TGA) for 2011.
The adverse event following immunisation (AEFI) report for 2011 summarises Australian passive surveillance data for adverse events reported to the Therapeutic Goods Administration (TGA) for 2011, and describes reporting trends over the 12-year period 2000 to 2011. There were 2,327 AEFI records for vaccines administered in 2011, a decrease of 40% from 3,894 in 2010. The decrease in 2011 was attributable to a drop in the reports following seasonal influenza (2,354 to 483) and pandemic H1N1 (pH1N1) influenza vaccines (514 to 2). The most commonly reported reactions were ISR, fever, allergic reactions and malaise. Only 7% of all the reported adverse events were categorised as serious.
The monitoring of adverse events following immunisation by the TGA allows surveillance of the safety of vaccines used in Australia. Reports of suspected AEFI are notified to TGA by state and territory health departments, health professionals, vaccine manufacturers and members of the public. All the reports are reviewed by TGA and collated in a central database. NCIRS is funded by the Australian Government Department of Health and Ageing to analyse de-identified data and produce AEFI surveillance reports.
The complete 2011 report can be found online at: Australian Government Department of Health and Ageing website. The report is prepared by the Surveillance team at the National Centre for Immunisation Research and Surveillance.
December 2012 - Newsletter
Dec 2012 - NewslettersDownload the file »
August 2012 - Newsletter
Aug 2012 - NewslettersDownload the file »
April 2012 - Newsletter
Apr 2012 - NewslettersDownload the file »
Ethical Issues In Immunisation Seminar - held on 26 March 2012
Mar 2012 - Events
The Ethical Issues in Immunisation Seminar was held on March 26th, at The Darlington Centre, University of Sydney.
This 1-day seminar addressed the major ethical issues facing immunisation programs in Australia today:
* What level of vaccine risk is acceptable and who should decide?
* Is it unethical not to have a no-fault compensation scheme for serious adverse events attributed to vaccination?
* How far can we go in getting people to be vaccinated?
* Is the current system for funding vaccines sufficient?
* How can vaccine programs incorporate public values?
Speakers included Marie Bismark, Stacy Carter, Andrea Forde, Claire Hooker, David Isaacs, Heath Kelly, Ian Kerridge, Julie Leask, Kristine Macartney, Roger Magnusson, Helen Marshall, Peter Massey, Terry Nolan, Glenn Salkeld, Cameron Stewart.
PDFs of presentations given on the day are available via the links below. Please note files are large and may take a couple of minutes to download.
No-fault compensation for vaccine related injuries - the NZ experience - by Marie Bismark
How far can government go in promoting vaccination? - by Robert Hall
No fault compensation for adverse events attributed to vaccination - by Heath Kelly
A little bit more ethics on power and persuasion in immunisation - by Ian Kerridge
What is an acceptable risk and who decides? - by Roger Magnusson
Funding population immunisation in Australia - by Terry Nolan
An economic perspective on the selection and reimbursement of vaccines in Australia - by Glenn Salkeld
Legal arguments in favour of a vaccination compensation scheme - by Cameron Stewart
Click here for a PDF version of the Ethical Issues in Immunisation Seminar program
HPV vaccination study
Jan 2012 - News
If you have a son or daughter aged 11-13, then we are interested in what you and your child have to say about HPV vaccination.
It does not matter if your child has had the HPV vaccine. We would like to ask you both questions about HPV and the HPV vaccine. Interviews of you and your child will take around one hour to complete, and we will use this information to develop a decision-making tool for young people and their parents to use together, to help them make a decision about HPV vaccination. You will be reimbursed for travel.
If you or anyone you know is interested in this study, please Click here or contact Robyn Cree at firstname.lastname@example.org
December 2011 - Newsletter
Dec 2011 - NewslettersDownload the file »
Workshop: Progress toward control of meningococcal disease - held on 15 November 2011
Nov 2011 - Events
Held on 15 November 2011 in Melbourne, this scientific workshop brought together national and international experts to share the latest information on the biology, epidemiology, prevention and complications of meningococcal disease.
October 2011 - Newsletter
Oct 2011 - NewslettersDownload the file »
National Pertussis Workshop - held on 25 & 26 August 2011
Aug 2011 - Events
Hosted by NCIRS on 25 and 26 August 2011 at Darling Harbour in Sydney, the National Pertussis workshop brought together national and international experts to share the latest information on pertussis. Topics included epidemiology, vaccine efficacy, vaccine schedules, new strategies and future steps and priorities on pertussis.
Click here for a PDF version of the National Pertussis Workshop program/abstract booklet
PDFs of presentations can be accessed via the presentation title links below. Please note files are large and may take a couple of minutes to download.
Day 1 - 25/8/2011
Is Australia the world capital of pertussis? - by Peter McIntyre
Pertussis control - has Canada got it right? - by Scott Halperin
Risk factors for death from pertussis (California)? - by Kath Harriman
Severity of pertussis in hospitalised children - by Helen Marshall
What do we know about source of infant infection? - by Kristine Macartney
Pertussis strains - do they matter? - by Ruiting Lan
Vaccine efficacy and surrogate markers - by Peter McIntyre
Vaccine effectiveness & duration of immunity - US overview - by Tom Clark
Vaccine effectiveness & duration of immunity - Australia - by Helen Quinn
What do we know about impact of vaccines on transmission? - by Patricia Campbell
Pertussis vaccine schedules - what can serosurveillance and modelling tell us - by Jodie McVernon
Day 2 - 26/8/2011
Experience with cocoon implementation and impact -
California - by Kath Harriman
US overview - by Tom Clark
Australia - by Stephen Lambert
Maternal immunisation - can we do it, what can we expect? - by Scott Halperin
Neonatal immunisation - can we do it, what can we expect? - by Nick Wood
Live attenuated pertussis vaccines - are they the future of pertussis control? - by Camille Locht
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next